Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled Trial

Published:2017-06-09 Issue:2 Volume:7 Page:177-187
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Noda Yoshinori¹,Nilsson Catarina²,Shimada Hitoshi¹,Kim Hyosung¹,Lundström Torbjörn²,Yajima Toshitaka³

Affiliation:

1. AstraZeneca KK; Kita-ku Osaka Japan

2. AstraZeneca Gothenburg; Mölndal Sweden

3. AstraZeneca KK; Chiyoda-ku Tokyo Japan

Funder

AstraZeneca KK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference27 articles.

1. World Health Organization WHO Mortality Database http://apps.who.int/healthinfo/statistics/mortality/whodpms/ 2016

2. Serum triglycerides and risk of coronary heart disease among Japanese men and women;Iso;Am J Epidemiol,2001

3. Mortality risk of triglyceride levels in patients with coronary artery disease;Kasai;Heart,2013

4. Increased triglyceride may determine the sites of coronary arterial lesions;Nakamura;Ann N Y Acad Sci,1990

5. Triglycerides and remnant particles as risk factors for coronary artery disease;Nakamura;Curr Atheroscler Rep,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Icosapent Ethyl: An Open‐Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2022-07-03

2. Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study;Clinical Pharmacology in Drug Development;2020-06-21